Prepare for the Internal Medicine II Test with engaging flashcards and multiple-choice questions. Each question is detailed with hints and explanations. Gear up your knowledge for success!

Multiple Choice

Hyponatremia with euvolemia due to SIADH—what is the recommended initial management and the safe rate of correction?

In SIADH with euvolemic hyponatremia, the hallmark issue is inappropriate free-water retention leading to dilution of serum sodium. The best initial management is fluid restriction to limit free-water intake and, crucially, to address the underlying cause driving ADH release (such as adjusting or stopping offending medications or treating the underlying illness). This approach allows the kidneys to excrete the extra water and Na to rise toward normal. The safe rate of correction is important to prevent osmotic demyelination syndrome. Aim to raise serum sodium gradually, typically no more than about 6-8 mEq/L in the first 24 hours and not more than ~8 mEq/L per day thereafter. Hypertonic saline is reserved for patients with severe, life-threatening symptoms (for example, seizures or coma) and is not the initial approach in a stable, euvolemic SIADH case. Intravenous dextrose adds free water and can worsen hyponatremia, while volume expansion with normal saline can exacerbate the problem in SIADH by increasing free water retention, so those are not appropriate first-line choices here.

In SIADH with euvolemic hyponatremia, the hallmark issue is inappropriate free-water retention leading to dilution of serum sodium. The best initial management is fluid restriction to limit free-water intake and, crucially, to address the underlying cause driving ADH release (such as adjusting or stopping offending medications or treating the underlying illness). This approach allows the kidneys to excrete the extra water and Na to rise toward normal.

The safe rate of correction is important to prevent osmotic demyelination syndrome. Aim to raise serum sodium gradually, typically no more than about 6-8 mEq/L in the first 24 hours and not more than ~8 mEq/L per day thereafter.

Hypertonic saline is reserved for patients with severe, life-threatening symptoms (for example, seizures or coma) and is not the initial approach in a stable, euvolemic SIADH case. Intravenous dextrose adds free water and can worsen hyponatremia, while volume expansion with normal saline can exacerbate the problem in SIADH by increasing free water retention, so those are not appropriate first-line choices here.